Cargando…

Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects

From 2012 to 2016, Gavi, the Vaccine Alliance, provided support for countries to conduct small-scale demonstration projects for the introduction of the human papillomavirus vaccine, with the aim of determining which human papillomavirus vaccine delivery strategies might be effective and sustainable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Botwright, Siobhan, Holroyd, Taylor, Nanda, Shreya, Bloem, Paul, Griffiths, Ulla K., Sidibe, Anissa, Hutubessy, Raymond C. W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5634534/ https://www.ncbi.nlm.nih.gov/pubmed/29016596 http://dx.doi.org/10.1371/journal.pone.0182663

Ejemplares similares

Gavi HPV Programs: Application to Implementation
por: Hanson, Celina M., et al.
Publicado: (2015)

Costs of Introducing and Delivering HPV Vaccines in Low and Lower Middle Income Countries: Inputs for GAVI Policy on Introduction Grant Support to Countries
por: Levin, Ann, et al.
Publicado: (2014)

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya
por: Ojal, John, et al.
Publicado: (2019)

Implementation strategy and cost of Mozambique’s HPV vaccine demonstration project
por: Soi, Caroline, et al.
Publicado: (2019)

Health and economic benefits of single-dose HPV vaccination in a Gavi-eligible country
por: Burger, Emily A., et al.
Publicado: (2018)

The Full Value of Vaccine Assessments (FVVA): a framework for assessing and communicating the value of vaccines for investment and introduction decision-making
por: Hutubessy, Raymond, et al.
Publicado: (2023)

Evaluating Global Health Partnerships: A Case Study of a Gavi HPV Vaccine Application Process in Uganda
por: Kamya, Carol, et al.
Publicado: (2016)

A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool
por: Hutubessy, Raymond, et al.
Publicado: (2012)

The GAVI Alliance and the ‘Gates approach’ to health system strengthening
por: Storeng, Katerini T.
Publicado: (2014)

Challenges to sustainable immunization systems in Gavi transitioning countries
por: Cernuschi, Tania, et al.
Publicado: (2018)

‘It takes two to tango’: Bridging the gap between country need and vaccine product innovation
por: Archer, Rachel A., et al.
Publicado: (2020)

Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand
por: Rattanavipapong, Waranya, et al.
Publicado: (2020)

Acting on the call: A framework for action for rapid acceleration of access to the HPV vaccination in low‐ and lower‐middle‐income countries
por: Kumar, Somesh, et al.
Publicado: (2020)

Health and economic impact of rotavirus vaccination in GAVI-eligible countries
por: Kim, Sun-Young, et al.
Publicado: (2010)

GAVI supply chain strategy people and practice evidence review
por: Steele, Pamela
Publicado: (2014)

WHO-led consensus statement on vaccine delivery costing: process, methods, and findings
por: Levin, Ann, et al.
Publicado: (2022)

Achieving immunization agenda 2030 coverage targets for 14 pathogens: Projected product and immunization delivery costs for 194 Countries, 2021–2030
por: Sriudomporn, Salin, et al.
Publicado: (2022)

Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study
por: Debellut, Frédéric, et al.
Publicado: (2019)

Comparative evaluation of the potential impact of rotavirus versus hpv vaccination in GAVI-eligible countries: A preliminary analysis focused on the relative disease burden
por: Kim, Sun-Young, et al.
Publicado: (2011)

Estimating the delivery costs of COVID-19 vaccination using the COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool: the Lao People’s Democratic Republic experience
por: Yeung, Karene Hoi Ting, et al.
Publicado: (2023)

Cost-effectiveness of routine and campaign use of typhoid Vi-conjugate vaccine in Gavi-eligible countries: a modelling study
por: Bilcke, Joke, et al.
Publicado: (2019)

Costing oral cholera vaccine delivery using a generic oral cholera vaccine delivery planning and costing tool (CholTool)
por: Morgan, Winthrop, et al.
Publicado: (2020)

Cost-Utility Analysis of Universal Maternal Pertussis Immunisation in Thailand: A Comparison of Two Model Structures
por: Botwright, Siobhan, et al.
Publicado: (2022)

Challenges in educating women about human papillomavirus (HPV) and HPV screening test results: Experience from an HPV demonstration project in North-Eastern Thailand
por: Senkomago, Virginia, et al.
Publicado: (2016)

Exploring the influence of the Global Fund and the GAVI Alliance on health systems in conflict-affected countries
por: Patel, Preeti, et al.
Publicado: (2015)

Overcoming challenges to sustainable immunization financing: early experiences from GAVI graduating countries
por: Saxenian, Helen, et al.
Publicado: (2015)

Resource Allocation Strategies to Increase the Efficiency and Sustainability of Gavi’s Health System Strengthening Grants
por: Mimche, Honoré, et al.
Publicado: (2018)

Gavi Support for Typhoid Conjugate Vaccines: Moving From Global Investments to Country Introduction
por: Soble, Adam, et al.
Publicado: (2020)

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making
por: Botwright, Siobhan, et al.
Publicado: (2020)

Assessing vaccine introduction and uptake timelines in Gavi-supported countries: are introduction timelines accelerating across vaccine delivery platforms?
por: Luthra, Karuna, et al.
Publicado: (2021)

Programme costs in the economic evaluation of health interventions
por: Johns, Benjamin, et al.
Publicado: (2003)

Demonstrating cost-benefit for forensic laboratory resources: Project Resolution
por: Wickenheiser, Ray A.
Publicado: (2021)

Strengthening immunisation supply chain systems through the GAVI Alliance Immunisation Supply Chain Strategy
por: Brownlow, Kaleb, et al.
Publicado: (2014)

Assessing the value of human papillomavirus vaccination in Gavi-eligible low-income and middle-income countries
por: Ochalek, Jessica, et al.
Publicado: (2020)

Lessons Learned From Implementing Prospective, Multicountry Mixed-Methods Evaluations for Gavi and the Global Fund
por: Carnahan, Emily, et al.
Publicado: (2020)

Ensuring vaccine potency and availability: how evidence shaped Gavi's Immunization Supply Chain Strategy
por: Prosser, Wendy, et al.
Publicado: (2022)

Mapping of Pro-Equity Interventions Proposed by Immunisation Programs in Gavi Health Systems Strengthening Grants
por: Ducharme, Joelle, et al.
Publicado: (2023)

Evaluating Country Performance After Transitioning From Gavi Assistance: An Applied Synthetic Control Analysis
por: Kolesar, Robert John, et al.
Publicado: (2023)

Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999–2014)
por: Gandhi, Gian
Publicado: (2015)

Costs associated with delivering HPV vaccination in the context of the first year demonstration programme in southern Mozambique
por: Alonso, Sergi, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gg8kbdd6tnjche9do3176dpivs